Neurana Pharmaceuticals
About:
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Website: https://neuranapharma.com/
Twitter/X: neuranapharma
Top Investors: Longitude Capital, Sofinnova Investments, New Leaf Venture Partners, H.I.G. BioHealth Partners, MagnaSci Ventures
Description:
Neurana Pharmaceuticals is a biotechnology company that is currently developing a novel treatment for acute muscle spasms. The company was founded in 2013 and headquartered in California, United States.
Total Funding Amount:
$60M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2013-01-01
Contact Email:
Info(AT)neuranapharma.com
Founders:
David Hale, Judy Caron
Number of Employees:
11-50
Last Funding Date:
2018-05-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai